Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals, Inc. (Amphastar Pharmaceuticals), formerly known as the New Drug Research Center (NDRC), is an integrated specialty private pharmaceutical company that is engaged in the development, manufacture, marketing and sale of generic and proprietary injectable and inhalation products using new technologies and delivery systems. Overall, the company manufactures and sells about 67 generic injectable and inhalation products. Its lead products include primatene mist, amphadase, cortrosyn, lidocaine jelly, naloxone and phytonadione. Amphastar Pharmaceuticals has a pipeline of products and is wide open to partner its proprietary drug development pipeline and out-licensing its patented technologies. The company is headquartered at Rancho Cucamonga in California, the US.
Company Index Score
| Current Index Score | Historical Index Score |
![]() |
|
| |
Latest tweets
More from New Statesman
- Online writers:
- Steven Baxter
- Rowenna Davis
- David Allen Green
- Mehdi Hasan
- Nelson Jones
- Gavin Kelly
- Helen Lewis
- Laurie Penny
- The V Spot
- Alex Hern
- Martha Gill
- Alan White
- Samira Shackle
- Alex Andreou
- Nicky Woolf in America
- Bim Adewunmi
- Glosswitch
- Kate Mossman on pop
- Ryan Gilbey on Film
- Martin Robbins
- Rafael Behr
- Eleanor Margolis
- Tools and services:
- Polls
- Predictions
- Archive
- Magazine
- PDF edition
- RSS feeds
- Advertising
- Subscribe
- Special supplements
- Stockists

